Living Donor Liver Transplantation for Hepatocellular Carcinoma: It Is All about Donors?
Background: Live-donor liver transplantation (LDLT) is a valuable option for patients with hepatocellular carcinoma (HCC) as compared with deceased-donor liver transplantation (DDLT); the tumor could be eradicated early.
Main Authors: | Saidi, R. F., Li, Y., Shah, S. A., Jabbour, N. |
---|---|
Format: | Online |
Language: | English |
Published: |
Avicenna Organ Transplantation Institute
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089325/ |
Similar Items
-
Outcomes of Patients with Portal Vein Thrombosis Undergoing Live Donor Liver Transplantation
by: Saidi, R. F., et al.
Published: (2014) -
Living Donor Liver Transplantation for Patients with Hepatocellular Carcinoma
by: Akamatsu, Nobuhisa, et al.
Published: (2014) -
Repeated-Measures Implication of Hepatocellular Carcinoma Biomarkers in Living Donor Liver Transplantation
by: Chiu, King-Wah, et al.
Published: (2015) -
Analysis of Donor Motivations in Living Donor Liver Transplantation
by: Abdeldayem, Hesham, et al.
Published: (2014) -
Can living donor liver transplantation offer similar outcomes to deceased donor liver transplantation using expanded selection criteria for hepatocellular carcinoma?
by: Chen, Li-Ping, et al.
Published: (2015)